Search for: "Pharmaceutical Research and Manufacturers of America" Results 161 - 180 of 410
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Feb 2015, 9:54 am by Jeremy Malcolm
And it's never short for ideas, because the International Intellectual Property Alliance (IIPA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) supply complaints galore in the phonebook-length submissions that they file every year. [read post]
21 Jan 2015, 3:02 pm
To paraphrase Calvin Coolidge, “The business of America is business. [read post]
21 Jan 2015, 6:28 am by Lisa Baird
On December 29, 2014, the Pharmaceutical Research and Manufacturers of America (“PhRMA”), the Biotechnology Industry Organization (“BIO”), and the Generic Pharmaceutical Association (“GPhA”) jointly filed a Petition for a Writ of Certiorari (Case No. 14-751) with the United States Supreme Court, asking for review of a case with widespread implications for pharmaceutical manufacturers and distributors… [read post]
21 Nov 2014, 5:02 am by Terry Hart
Landmark Trade Deal at Risk Without Strong Intellectual Property Laws — “The nature of the TPP’s IP provisions matter greatly to the United States because America’s competitive advantage in the global economy increasingly lies in innovation-based industries—such as life sciences (pharmaceuticals and medical devices), information and communications technologies, digital services, music and film, aerospace, and advanced manufacturing—that… [read post]
23 Oct 2014, 3:27 pm
The Pharmaceutical Research and Manufacturers of America (PhARMA) is unhappy with the billions of dollars the drug industry rakes in every year, so it has filed another lawsuit to stop needy medical facilities from getting certain drugs at discount prices. [read post]
18 Oct 2014, 2:30 pm by Guest Blogger
There was little incentive for research on safety or effectiveness. [read post]
10 Oct 2014, 7:54 am
  The pharmaceutical industry challenged this novel tariff through a lawsuit filed by trade organizations—Pharmaceutical Research and Manufacturers of America, the Generic Pharmaceuticals Association, and the Biotechnology Industry Organization—claiming that the ordinance violated the dormant Commerce Clause by wrongfully regulating interstate commerce. [read post]
6 Oct 2014, 7:03 am by Dr. Shezad Malik
Takeda Pharmaceuticals America Inc., 120702272, Philadelphia County Court of Common Pleas. [read post]
23 Sep 2014, 10:49 am by Lisa Baird
The defense in Solis – supported in an amicus curiae brief filed by the Pharmaceutical Research and Manufacturers of America– argues that the dissemination of the medical articles was not “false” in that it did not present incorrect or misleading information, was protected by First Amendment, and did not lead to the submission of any false claims. [read post]
18 Sep 2014, 11:17 am
  The Pharmaceutical Research & Manufacturers of America (“PhRMA”) is sick and tired of its members being shaken down for many millions of dollars by government “enforcement” actions seeking to monetize the FDA’s questionable interpretation. [read post]
23 Jul 2014, 6:44 am by Debra A. McCurdy
Note that the Pharmaceutical Research and Manufacturers of America (PhRMA), which filed the original lawsuit on the 340B orphan drug regulation, has filed a motion asserting that “HHS’s actions are in direct circumvention” of the prior court ruling, and challenging HRSA’s authority to implement this policy through an interpretive rule. [read post]
21 Jul 2014, 11:00 am by Schachtman
See “Silicosis, Lung Cancer, and Evidence-Based Medicine in North America” (July 4, 2014). [read post]
24 Apr 2014, 11:42 am
Even Congress asked Gilead, the drug’s manufacturer, to justify its cost. [read post]
8 Apr 2014, 10:28 am by Joe Consumer
“This is what corporations in America do,” she said. [read post]
20 Feb 2014, 8:36 am
The policy's staunch critics include the Pharmaceutical Research and Manufacturer's of America, the Maine Pharmacy Association and big-name drug manufacturers such as Pfizer and Johnson & Johnson. [read post]
13 Oct 2013, 1:05 pm
” Both professors were responsive to The Post, but the Pharmaceutical Research and Manufacturers of America declined to comment. [read post]